Bio-Pharm Solutions Co., Ltd. has expanded its clinical pipelines from infantile spasms (IS) to status epilepticus (SE) and Alzheimer's disease. Based on the performance of its first pipeline, an infantile spasms drug, BIo-Pharm Solutions is currently planning to capitalize through an IPO to advance other clinical development projects.
Bio-Pharm Inc Generic Lactulose Receives Approval In US
Ahmedabad-headquartered Rs 58 billion worth drug firm Torrent Pharmaceuticals on Thursday made its sixth acquisition in the last five years to put its fledgeling US business on a recovery path - it bought a generic pharmaceutical and over the counter (OTC) drugs company Bio-Pharm Inc (BPI) for an undisclosed amount. Market sources peg the deal size at around a few billion rupees and much lesser than Torrent's latest buy Unichem (a Rs 36 billion deal)
Bio-Pharm’s Generic Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride Receives Approval In US